NanoMedicine is a Research Division in The University of Texas Department of Biomedical Engineering at The University of Texas Health Science Center at Houston , directed by Professor Mauro Ferrari. The University of Texas Department of Biomedical Engineering is an Inter-Institutional Department formed by three University of Texas System components, The University of Texas at Austin, University of Texas M. D. Anderson Cancer Center and The University of Texas Health Science Center at Houston.

The Division of NanoMedicine focuses on inter-disciplinary research to combine nano-engineering, mathematical modeling and biomedical sciences to develop nanotechnology enabled therapeutic and diagnostic platforms for combating diseases including cancer, cardiovascular diseases and infectious diseases.

Our ongoing research projects include:

• Early Detection of Disease from Blood Proteomic Signatures
• Injectable NanoVectors for Directed (Targeted/personalized) Therapeutics
• Intelligent Implants for Controlled Time Release of Therapy
• BioNanoScaffolds for Post-Traumatic OsteoRegeneration

More on research...

Selected Publications

Ferrari, M (2008).
Nanogeometry: Beyond Drug Delivery
Nature Nanotechnology 3(3):131-132.

Sanhai, W, Sakamoto, J, Canady, R, and Ferrari, M (2008).
Seven Challenges for Nanomedicine
Nature Nanotechnology(3):242-244.

Tasciotti, E, Liu, X, Plant, K, Leonard, A, Price, B, Cheng, M, Decuzzi, P, Tour, J, Robertson, F, and Ferrari, M (2008).
Mesoporous Silicon Particles as a Multistage Delivery System for Imaging and Therapeutic Applications
Nature Nanotechnology 3(3):151-157.

Ferrari, M (2006).
nan'o tech nol'o gy n.
Nature Nanotechnology 1:8-10.

Ferrari, M (2005).
Cancer nanotechnology: opportunities and challenges
Nature Reviews Cancer 5:161-171.

Liotta, L, Ferrari, M, and Petricoin, E (2003).
Clinical proteomics: Written in blood
Nature 425:905.